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OBJECTIVE: To verify how reliable is the information provided by parents about the history of varicella in their children.
METHODS: 204 parents of previously healthy children attending two municipal day-care centers of São Paulo city were interviewed
between August 2003 and September 2005. A standardized form was filled out with information regarding age, sex, history of
varicella and other diseases, drug use and antecedent of immunization, After medical history, physical examination and checking
of immunization records, 5 ml of blood were collected for ELISA (in house) varicella test. Exclusion criteria were: age less than
1 year or more than 60 months, previous immunization against chickenpox, presence of co-morbidities or recent use of
immunosuppressive drugs. Data were filed in a data bank using the Excel 2003 Microsoft Office Program and stored in a PC
computer. The exact Fisher test was employed to calculate sensibility, specificity, positive and negative predictive values of
history of varicella informed by children’s parents.
RESULTS: The age of the children varied from 12 to 54 months (median, 26 months; 49 (24%) children had positive history of
varicella, 155 (76%) a negative or doubtful history. The predictive positive and negative values of the information were 90% and
93%, respectively (p = 0.0001).
CONCLUSIONS: The degree of reliability of information about history of varicella informed by parents of children attending
day care centers was high and useful to establish recommendations on varicella blocking immunization in day-care centers.
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INTRODUCTION
The cause of varicella is the varicella-zoster (VVZ) vi-
rus that affects humans and a few higher primates. The pri-
mary infection develops the varicella condition (pox rash),
which is characterized by the outburst of papulovesicular
exanthematic lesions that are polymorphic, with central dis-
tribution. On the other hand, virus reactivation is the cause
of herpes zoster. The disease is spread worldwide and when
no vaccination program is in place, most cases will occur
during childhood.
In previously healthy children, varicella is an acute and
self-limiting disease, with low degree of fatality; however,
morbidity is high and may give rise to different complica-
tions, including death 1-6. Adults and those with underly-
ing diseases are at greater risk for complications. However,
in absolute figures, most of the complications,
hospitalizations, and deaths have been reported in previ-
ously healthy children 7-11.
Recent studies have indicated that children in day-care
units are at greater risk for complications and death from
varicella 8-10. In the State of São Paulo, as of September 2003,
the State Health Secretary has recommended blockade vac-
cination in day-care centers as soon as the first case of vari-
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cella is reported 12. The vaccine is recommended for chil-
dren over one year of age and for adults with negative or
doubtful varicella history without a prior serologic test 2.
Although a few studies have assessed the positive and
negative predictive value of the information on the vari-
cella antecedents in children and adults 13-19, no study was
found in the literature assessing the reliability of the in-
formation provided by parents of children attending Gov-
ernment day-care centers in the State of São Paulo. Thus,
it was decided to conduct this study, because such infor-
mation is critical in order to establish appropriate public
policies to develop vaccination guidelines.
Objectives
To assess the sensitivity and specificity of the information
provided by parents on their children’s varicella history, at day-
care center, by comparing their information with serological
tests (ELISA, in house technique) and their corresponding
positive (PPV) and negative (NPV) predictive value.
Casuistics and Methods
This was a cross-sectional study covering the period of
August 2003 to September 2005, conducted as an investi-
gation of varicella history with parents or caretakers of chil-
dren in the age group 12 to 60 months who attended two
municipal day-care units in São Paulo. Blood collection for
the performance of ELISA serologic tests was carried out
in these children.
Population
The study field included two municipal day-care units
located in the west district of the city of São Paulo, that
cater for a population in which family income is lower than
three minimum monthly wages (roughly equivalent
US$550.00 per month take home money). The units were
selected as a convenient sample, because they are located
close to the Research Centers (laboratory and hospital) in-
volved in this study.
The universe was exclusively composed of previously
healthy children, aged between 12 and 60 months, whose
parents freely consented to take part in the study. Children
previously vaccinated against varicella and those with dis-
eases that could affect immunity or who had been given oral
corticosteroids during the last three months were excluded.
METHODS
After approval by the Ethics Committee/Institutitonal
Review Board of the Institutions involved in the investiga-
tion, the Project was presented to the Day-Care Units Board.
The study objective and procedures were detailed to the chil-
dren’s caretakers in different meetings, each gathering 20
parents. After signing the Free and Informed Consent Form,
parents, under the supervision of the investigator, filled out
a previously tested form with data on age, gender, disease
history, use of medications and the child’s vaccinal status.
Later, on pre-set dates, anamnesis, physical exams and
blood collection were performed. Anti-VVZ antibodies
were detected by an in-house ELISA test that has been
tested and described in another study8.
Inclusion Criteria
Children from 12 to 60 months of age, without prior
varicella vaccination and no disease or drug use that could
hamper the immunologic response.
Exclusion Criteria
Children with less than 12 or more then 60 months of
age, prior varicella vaccination, disease or use of drugs af-
fecting immunity, missed material collection visit, and fail-
ure to obtain parent’s informed consent.
Procedures
On the blood collection set date, the study investiga-
tors performed anamnesis, physical exams and reviewed the
children vaccination records. Children with negative or
doubtful history of varicella were vaccinated soon after
blood collection, provided there was no condition that
would contraindicate such vaccination.
Data Base and Statistical Analysis
The following variables were reviewed: gender, age,
varicella history and vaccinal status.
All the information collected were entered in a data
bank using the Excel 2003 Microsoft Office Program and
filed in a PC computer.
The statistical analysis was based on frequency distribu-
tion in absolute values and in percentages, average and me-
dian. The exact Fisher test was used to calculate sensitivity
(Se), specificity (Sp), positive (PPV) and negative (NPV) pre-
dictive value with 95% confidence interval (CI), (P < 0.05).
OUTCOME
The information collected from 204 children was re-
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viewed. Out of this total, 49 children (24%) had positive
antecedents for varicella, and 155 (76%), negative (n = 142)
or doubtful (n = 13) antecedents.
Data on gender and age group distribution of the children
enrolled in the two day-care units is reported in Table 1.
Out of the total of 49 children who reported a positive
history, only five children (10%) exhibited negative serol-
ogy and out of 155 children with negative or doubtful his-
tory, 11 (7%) exhibited positive serology (Table 2).
The sensitivity of the information was 0.80 (CI 95%:
0.67-0.89) and the specificity was 0.97 (CI 95%: 0.92 –
0.99). The information positive predictive value was 0.90
(CI95%: 0.78 – 0.97) and the negative predictive value was
0.93 (CI 95%: 0.88 – 0.96).
Taking into account only the group of children whose
parents indicated having no doubts on either positive or
negative varicella history, sensitivity increased to 0.88 and
specificity continued at 0.97 as shown in Table 3.
DISCUSSION
Very few studies on the reliability of information on
children’s varicella history are available 15-19. The majority
of the published investigations was carried out to assess the
positive and negative predictive value of the information
on varicella history and include children older than seven,
adolescents and adults.
Young adults with varicella negative antecedents gen-
erally show positive serology for the disease 13,14. Lieu et
al (1998) 15 reported that varicella antibodies seroprevalence
in children between 7 and 12 years of age with negative
or uncertain varicella history varied between 9% and 68%
and grew with the child’s increasing age. Despite the low
level of reliability of the information on negative varicella
history, the level of reliability of the family’s information
on varicella’s positive antecedents was high (95%).
In two recent studies, designed to assess parent’s infor-
mation reliability in connection with varicella history in
young refugees of different countries, it was reported that
the positive predictive value was high (88% to 100%) while
the negative predictive value was low (28 to 66%) 18,19.
In this study, information on positive and negative his-
tory of the disease was considered reliable. This is prob-
ably due to the high prevalence of varicella in children, es-
pecially among those attending day-care centers, because
they get an earlier exposure to the disease 20. Besides, the
ages of children with negative (median = 22 months; range
12 – 52 months) and positive antecedent for varicella (me-
dian = 38 months; range 15 – 52 months) were low, and
probably the risk of a memory bias was low too.
The varicella vaccine is highly effective against seri-
ous forms of the disease, although protection against mild
forms is not as good (80%) 1,21-24.
Varicella is a highly contagious disease, particularly af-
ter close contact in the household or in collective environ-
ments such as day-care centers 25,26. The São Paulo Health
State Secretary’s recommendation to vaccinate children
enrolled in day-care units is due to the higher death rate
in this group 10.
In 2003, some 60,000 cases of varicella were reported
Table 3 - Distribution of children* (n) whose parents claimed
to be sure about varicella antecedents. Distribution according
to serologic tests. São Paulo Municipality, August 2003 to
September 2005.
Varicella Positive Negative
Antecedents Serology Serology Total
n n  n (%)
Positive 44 5 49 (26)
Negative 6 136 142 (74)
Total 50 141 191 (100)
* Excluding 13 cases whose information was doubtful.
Table 2 -  Distribution of children included in the study (n)
according to their parents’ information on varicella history
and serological response. São Paulo Municipality, August
2003 to September 2005.
Varicella History Positive Negative
Serology Serology Total
n n  n (%)
Positive 44 5 49  (24)
Negative or Doubtful 11 144 155 (76)
Total 55 149 204 (100)
Table 1 -  Distribution of 204 children included in the study according to gender and age. São Paulo Municipality, August
2003 to September 2005.
Age Group Girassol Day-Care Center São  José Day-Care Center Total
(in months) Male Female Male Female Male Female
12 - 23 25 17 21 21 46 38
24 - 35 18 23 12 10 30 33
36 - 49 16 11 18 8 34 19
50 - 60 -   1   1 2 1 3
Total 59 52 52 41 111 93
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in the State of São Paulo, of which 60 were fatal. Although
50% of the cases reported involved children younger than
five, about 80% of the death cases were reported in chil-
dren in this age-group 12.
Despite the fact that this trial indicated that informa-
tion on varicella history in younger children is highly reli-
able to establish a vaccination program, it is critical to re-
member that immunization after a close contact is only ef-
fective if administered promptly, i.e. up to 72 hours after
the index case has been detected. In addition, because vari-
cella is highly transmissible indoors, a high vaccinal cov-
erage is required to prevent the spread of the disease in day-
care centers 1.
A blocking vaccination program in day-care units is
rather complex, as it requires prompt information convey-
ance, a survey of the children health conditions and of their
vaccination status in addition to trained staff available to
vaccinate in day-care units.
In different countries, varicella vaccination cost-benefit
studies have demonstrated that vaccination can be resource
saving, especially when taking into account the social costs
of the disease, such as parents’ labor absenteeism 1,5,27-29.
We are not aware of any study conducted in Brazil to as-
sess varicella vaccination cost-benefits. Nevertheless, the
number of death cases and complications due to varicella
in previously healthy children is not negligible, and effec-
tive measures to control the disease are necessary.
Finally, it should be pointed out that the acceptance of
new vaccines by the population depends on the level of in-
formation delivered to the parents concerning the safety and
efficacy of such vaccines. All the parents who took part in
this trial did receive information on the vaccine and on the
disease and gave their consent for their children’s vacci-
nation 30-32.
There are two aspects that offer a potential bias in this
study: the smaller number of children with positive varicella
history as compared to those with negative antecedents and
the ELISA test sensitivity to detect prior varicella occurrence.
Most of the children who were not included in the study were
children with a varicella positive history, whose parents re-
fused to allow blood to be drawn. Despite this screening bias,
the children universe analyzed was representative and helped
in drawing the conclusion that both positive and negative in-
formation were highly reliable (P < 0.001).
As to the serological test, although the ELISA test is
not considered the gold standard to help establish if the
child has or has not had the disease, it does exhibit good
sensitivity and specificity for varicella diagnosis and is the
most commonly used method in research, because it is
easier to perform than FAMA’s 33.
CONCLUSIONS
The reliability of the information on varicella history
in preschool children was high and useful as a guideline
for blockade vaccination programs in day-care centers.
RESUMO
Bricks LF, Pannuti CS, Sato HK, Vico ESR, Faria AM,
Souza VVAU, Sumita LM, Costa IC, Baldacci ER.
Confiabilidade da informação sobre antecedente de varicela
em crianças pré-escolares. Clinics. 2007;62(3):309-14.
OBJETIVOS: Verificar o grau de confiabilidade da
informação fornecida pelos pais de crianças atendidas em
creches sobre o antecedente de varicela.
MÉTODOS: Os pais de 204 crianças previamente saudá-
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veis matriculadas em duas creches da cidade de São Paulo
foram entrevistados entre Agosto de 2003 e Setembro de
2005 para preenchimento de um questionário padronizado
com informações sobre idade, sexo, antecedente de vari-
cela e outras doenças, uso de medicamentos e história va-
cina. Após anamnese, exame físico e verificação da car-
teira de vacinação, foram colhidos 5 ml de sangue para re-
alização do teste ELISA (in house) para varicela. Os crité-
rios de exclusão foram: idade < 1 ano ou acima de 60 me-
ses, vacinação prévia contra varicela, presença de
comorbidades e uso recente de imunossupressores. Os da-
dos foram registrados num banco de dados do programa
Excel 2003 Microsoft Office e armazenados em micro-
computador. Utilizou-se o teste exato de Fisher para cal-
cular a sensibilidade, especificidade e valores preditivo po-
sitivo e negativo das informações fornecidas pelos pais so-
bre o antecedente de varicela das crianças.
RESULTADOS: A idade das crianças variou entre 12 e 54
meses (mediana, 26 meses); 49 crianças (24%) tinham an-
tecedente positivo para varicela e 155 (76%) negativo ou
duvidoso. Os valores preditivo positivo e negativo da in-
formação foram de 90% e 93%, respectivamente (p =
0.0001).
CONCLUSÕES: O grau de confiabilidade das informa-
ções sobre varicela informadas pelos pais de crianças aten-
didas em creches foi elevado e útil para estabelecer reco-
mendações para vacinação de bloqueio de surtos de vari-
cela em creches.
UNITERMOS: Varicela-zóster. Crianças. Creches.
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